From: Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis
After extubation | |||||
---|---|---|---|---|---|
Mortality | Survival | ||||
M_aET (N = 11) | S_aET (N = 106) | Crude p | OR (95%CI) | Adjusted p | |
Age at MC onset (years) | 66.27 ± 13.93 | 52.31 ± 17.51 | 0.012* | 1.05 (0.997-1.104) | 0.063 |
Sex | |||||
 Female / Male | 6 / 5 | 63 / 43 | 0.754 | ||
Underlying diseases [n (%)] | |||||
 Hypertension | 2 (18.2) | 29 (27.4) | 0.725 | ||
 Diabetes mellitus | 3 (27.3) | 19 (17.9) | 0.431 | ||
 Dyslipidemia | 1 (9.1) | 3 (2.8) | 0.330 | ||
 COPD | 0 (0) | 3 (2.8) | 1.000 | ||
 Liver cirrhosis | 1 (9.1) | 1 (0.9) | 0.180 | ||
 CRF | 1 (9.1) | 2 (1.9) | 0.258 | ||
Acute comorbidity [n (%)] | |||||
 AMI | 0 (0) | 2 (1.9) | 1.000 | ||
 AKI | 3 (27.3) | 4 (3.8) | 0.018* | 4.3 (0.65-28.457) | 0.13 |
Medication for MG before admission [n (%)] | |||||
 Pyridostigmine only | 5 (45.5) | 15 (14.2) | 0.009* | 5.459 (1.17-25.472) | 0.031* |
 DMT with or without pyridostigmine | 4 (36.4) | 63 (59.4) | 0.201 | ||
 Prednisolone monotherapy | 3 (75) | 34 (54) | 0.050 | ||
 Immunosuppressant monotherapy | 1 (25) | 2 (3.2) | |||
 Prednisolone + Immunosuppressant | 0 (0) | 27 (42.9) | |||
 PE / DFPP [n (%)] | 5 (45.5) | 65 (61.3) | 0.307 | ||
Hemogram in 3 days before extubation | |||||
 Hb (g/dL) | 10.24 ± 1.14 | 11.81 ± 1.83 | 0.006* | ||
 Hb < 11 g/dL [n (%)] | 9 (81.8) | 35 (33) | 0.002* | 8.452 (1.455-49.089) | 0.017* |
 Platelet (x 109/L) | 202 ± 58.62 | 237.29 ± 112.39 | 0.308 | ||
 Platelet < 150 x 109/L [n (%)] | 2 (18.2) | 22 (20.8) | 1.000 | ||
 WBC (x 109/L) | 9.6 ± 2.93 | 13.75 ± 7.73 | 0.081 | ||
 WBC≧25 x 109/L [n (%)] | 0 (0) | 8 (7.5) | 1.000 | ||
 Neutrophil (%) | 71.98 ± 25.56 | 81.86 ± 11.41 | 0.232 | ||
 Lymphocyte (%) | 14.74 ± 13.53 | 12.12 ± 8.14 | 0.543 | ||
 NLR | 11.36 ± 11.11 | 13.73 ± 23 | 0.736 | ||
 Reintubation within 3 days | 3 (27.3) | 10 (9.4) | 0.105 | ||
 Mechanical ventilation more than 14 days | 2 (18.2) | 4 (3.8) | 0.098 |